BACKGROUND
the insulin receptor substrate  proteins represent key elements in insulin and insulin-like growth factor  actions, transducing pleiotropic effects on cellular function and regulating processes such as metabolism, growth, cell differentiation and survival  <cit> . at least four members  have been identified that differ with regard to tissue distribution, subcellular localization, developmental expression, binding to the insulin receptor, and interaction with src homology  <dig>  domains. they are all structurally characterised by n-terminal pleckstrin-homology  and phosphotyrosine-binding  domains, which are required for coupling to the activated insulin/igf receptors, and a c-terminal region with multiple sites for tyrosine phosphorylation by the receptors. irs proteins thus act as molecular adapters in recruiting, inter alia, a number of sh2-containing proteins binding to specific phosphorylated tyrosine residues. this leads to activation of different intracellular cascades  <cit> , one of which is the pi 3-kinase signalling cascade implicated in mediating the metabolic effects of insulin  <cit> .

the best-substantiated post-translational modification of irs proteins, in addition to tyrosine phosphorylation, is phosphorylation of specific serine residues. phosphorylation on these residues is associated both with inhibition of insulin-induced tyrosine phosphorylation of irs proteins and with facilitation of the effects of insulin  <cit> . phosphorylation catalysed by protein kinase c  isozymes  <cit> , c-jun n-terminal kinase   <cit> , inhibitor κb kinase  isozymes  <cit> , mitogen activated protein kinases   <cit>  and the mammalian target of rapamycin   <cit>  are all associated with reducing the ability of insulin to stimulate tyrosine phosphorylation of irs proteins and therefore may be part of the physiological and pathophysiological negative regulation of insulin signalling through the irs pathway. specific mechanisms explaining why serine phosphorylation leads to reduced tyrosine phosphorylation have not been completely identified, but candidates for this are reduced interaction of irs proteins with the insulin receptor  <cit>  and increased degradation of irs  <cit> . furthermore, phosphorylation of different residues can lead to different effects. thus, phosphorylation of serine  <dig> in rat irs- <dig>  is associated with reduced insulin signalling  <cit>  whilst phosphorylation of serine  <dig> has recently been suggested to facilitate insulin signalling  <cit> , although this has been contested  <cit> .

in addition to phosphorylation of different amino acid residues, insulin signalling through irs proteins has been shown to be regulated by at least two other mechanisms. prolonged signal transduction via phosphoinositide 3-kinase , which generates the lipid second messenger phosphatidylinositol  <dig> ,5-trisphosphate, has been shown to induce a state of insulin resistance in cells  <cit> , in part through degradation of irs- <dig>  <cit> . thus, insulin signalling can be negatively regulated through modulation of irs concentrations in cells, via degradation of the proteins in the proteasomal pathway  <cit> . the mechanism by which irs proteins are degraded by the proteasome is not completely understood, but the n-terminal ph and ptb domains are required  <cit> . in addition, the sub-cellular localisation of irs proteins may be important for appropriate insulin signalling. the sub-cellular localisation is not absolutely defined, with various lines of evidence pointing to potential places in the cell where the proteins can be found. in addition to the plasma membrane, irs proteins have been associated with high-density pellets  <cit>  implicating association with the cytoskeleton and recently also with the nucleus  <cit> . thus, irs proteins may be located to different parts of the cell where they carry out different functions.

multiple histone acetyltransferases  and histone deacetylases  control the state of histone acetylation and hence play a regulatory role in modulating the structure and function of chromatin  <cit> . about  <dig> hats have been detected to date, grouped in three different classes on the basis of structural properties. they all have one structural motif in common, the so-called a-motif responsible for acetyl coa recognition  <cit> . several hats also have non-histone substrates but it is not yet possible to identify putative acetylation sites within a protein simply by sequence analysis. generally, acetylation affects dna-binding, protein-protein interactions, protein stability, and protein localization  <cit> . the acetyl-mediated signals are reversed by hdacs that counteract the effects of hats by deacetylating lysine residues on histone tails. in higher eukaryotes, hdacs can be subdivided into three distinct groups known as classes i, ii, iii, according to similarities of their sequences to those of yeast founding members  <cit> . to date, four enzymes, hdac <dig>   <dig>   <dig> and  <dig>  are the known members of class i deacetylases  <cit> . hdac <dig> and  <dig> are the best characterised, and are chief constituents of the multiprotein transcriptional-repression complex sin3/hdac and the nucleosome remodelling deacetylase nurd/mi2/nrd complex  <cit> . complexes that contain class i hdacs bind to numerous transcription factors, either directly, or indirectly through the nuclear-hormone corepressors ncor and smrt . although all class i and ii hdacs can deacetylate histone tails, other cellular proteins can be specifically targeted by different hdacs as well, such as α-tubulin and importin-α  <cit> . recent developments have shown that the class i enzymes are regulated by phosphorylation, by casein kinase ii amongst others, which increases activity  <cit> . the fact that class ii enzymes are phosphorylated has been known for longer, a reaction which is associated with re-localization of the enzymes to the cytoplasm through interactions with 14-3- <dig> proteins  <cit> .

we now demonstrate that hdac <dig> interacts with irs- <dig> under conditions when the ability of cells to respond to insulin is compromised. as such, this interaction may constitute a new component of the negative regulation of irs protein function. we also show that irs- <dig> is acetylated, and that augmenting the acetylation level by treating cells with trichostatin a  or with short inhibitory rna oligonucleotides against hdac <dig> partially restores normal responsiveness to insulin.

RESULTS
interaction between irs- <dig> and hdac2
in an attempt to elucidate the regulation of irs- <dig>  we investigated inter-molecular interactions between irs- <dig> and potential binding partners using yeast two-hybrid screening through a human foetal brain plasmid cdna library. the system we used was the sos recruitment system as described in the methods section, which displays protein-protein interactions in the cytoplasm of yeast cells. in these experiments, full length human irs- <dig> was used as bait. two independent transformants from a screen of  <dig> ×  <dig> cdnas encoded the n-terminal portion of a  <dig> amino acid protein identified as histone deacetylase  <dig> .

to map the interaction site of hdac <dig> on irs- <dig> we used a gal4-based yeast two-hybrid system, where interactions take place in the nucleus of the yeast cell. cells were transformed with vectors encoding full length hdac <dig> and different truncation mutants of irs- <dig>  the truncations of irs- <dig> that were used were the ph domain , the ph-ptb domains  and the ph-ptb-pre-c-terminal domains . using growth of yeast cells on selective medium as a readout for interaction between hdac <dig> and irs- <dig> showed that the interaction requires the c-terminal portion of the irs- <dig> protein . in order to confirm the interaction further in vitro, we used a coupled in vitro transcription/translation system in which full length irs- <dig> and the hdac <dig> n-terminal portion from the initial yeast two-hybrid screen were transcribed and translated in the presence of s <dig> methionine. irs- <dig> was subsequently immunoprecipitated from the mixture and the proteins were resolved by sds-page. gels were then subjected to autoradiography. results showed that two radioactive protein bands were visible in the irs- <dig> immunoprecipitates  and their molecular weights corresponded to those of full length irs- <dig>  and truncated hdac <dig> . when the irs- <dig> antibody was boiled prior to immunoprecipitation  or omitted , no radioactive proteins were observed, indicating that the interaction between the two proteins is specific and not due to non-specific interactions with immunoglobulins or beads. thus, irs- <dig> and hdac <dig> proteins are able to interact with each other in cell-free systems.

to validate the interaction between irs- <dig> and hdac <dig> further and to ascertain whether irs- <dig> and hdac <dig> are associated in mammalian systems, we chose to work with mcf- <dig> cells , with a high endogenous expression of irs- <dig>  <cit> . the cells were stimulated with igf- <dig> or pma  for different time periods. immunoprecipitations with irs- <dig> antibody revealed that hdac <dig> was co-precipitated to a larger extent in pma-treated cells . in addition, the interaction between irs- <dig> and hdac <dig> was more visible in cells under prolonged stimulation with igf- <dig>  similar results were obtained during prolonged stimulation with insulin. considering that the ability of cells to respond to insulin and igf- <dig> is reduced after prolonged ligand stimulation or pma treatment, these data indicate that irs- <dig> and hdac <dig> associate when responsiveness is low and intracellular serine phosphorylation is increased. indeed, analysis of serine phosphorylation of irs- <dig> after treatment of cells with insulin or phorbol ester showed that pma treatment caused a significant increase in phosphorylation of irs <dig> on serine  <dig> , which has been associated with reduced phosphorylation on tyrosine residues by the insulin receptor , whereas insulin stimulation had no effect. in these experiments, cells were stimulated with insulin for  <dig> minutes and responsiveness was subsequently analysed by measuring tyrosine phosphorylation of irs- <dig> . responsiveness of the cells to insulin was compromised after pma treatment, thus confirming the apparent association of irs- <dig> with hdac <dig> under conditions of reduced cellular sensitivity to insulin.

to assess whether the interaction measured between irs- <dig> and hdac <dig> in vitro as described above occurs in vivo, we prepared lysates of liver tissues prepared from different mouse lines. the ob/ob mouse, which lacks functional leptin, was chosen as an insulin resistant animal model, and c57/bl <dig> was used as its genotype control. a ptp1b knockout mouse  <cit>  was used as an insulin-sensitised animal model and balb/cjj was used as its genotype control. irs- <dig> was immunoprecipitated from liver lysates and western blotted for co-immunoprecipitation of hdac <dig>  the data showed that whilst a clear interaction between irs- <dig> and hdac <dig> was seen in livers from ob/ob mice , no interaction was evident in the c57/bl <dig> control. in contrast, no interaction was evident in livers of ptp1b knockout animals, whilst the balb/cjj genotype control demonstrated a measurable interaction. taken together with the in vitro data, these results showed that irs- <dig> and hdac <dig> are able to interact with each other in the cytoplasmic compartment of cells and that the interaction occurs under conditions of reduced insulin sensitivity, both in mammalian cells and in animals. the cytoplasmic location of the interaction is interesting in view of the fact that hdac <dig> is considered to be largely a nuclear protein. in our work with cells and tissues, we have utilised lysis methods that are designed to retain nuclei intact and thereby minimise cross-contamination of compartments  <cit> . whilst we have not formally excluded the possibility of contamination of cytoplasmic extracts with nuclear lysate, thereby leading to the presence of hdac <dig>  we feel that the body of evidence indicates that cytoplasmic hdac <dig> is interacting with cytoplasmic irs- <dig> in our experiments. the yeast two hybid "sos recruitment system" is built on the rescue of cell growth through the interaction of proteins in the cytoplasm, which is how we detected this interaction. interestingly, it has recently been shown that histone deacetylase  <dig>  another class i histone deacetylase, which was considered to be exclusively nuclear, is present in a cytoplasmic protein complex by virtue of interaction with a cellular phosphatase complex  <cit> .

lysine acetylation of irs- <dig> and insulin signal transduction
the finding that hdac <dig> binds to irs- <dig> indicated that irs- <dig> might be an acetylated protein in which acetylation might be a regulated post-translational modification of the protein. indeed, the acetyl transferase tip <dig> has been reported to bind to the ph domain of irs- <dig>  <cit> , suggesting the irs- <dig> could be acetylated and deacetylated under different conditions. the lysine-acetylation status of irs- <dig> was assessed by western blotting of irs <dig> immunoprecipitated from mcf- <dig> cells after different treatments, using an antibody specific for acetylated lysine. trichostatin a , which is a non-selective inhibitor of both class i and class ii hdacs  <cit> , was used as a positive control. basal acetylation of the irs <dig> protein was evident in unstimulated cells . stimulation of cells with igf- <dig> did not alter the level of acetylation although the basal signal was low and small effects cannot therefore be ruled out. pma was also ineffective in altering the basal degree of acetylation of irs <dig> whereas treatment of cells with tsa caused a very large increase in signal . our data therefore show that irs- <dig> protein is acetylated on lysine residues, and the acetylation increases when hdac activity is generally inhibited. this represents a heretofore-undescribed post-translational modification of irs <dig> in addition to tyrosine/serine phosphorylation and ubiquitination previously described. tsa treatment did not induce phosphorylation of irs <dig> on serine  <dig> , nor did it modify the increase in serine  <dig> phosphorylation in the presence of pma .

the regulation and function of proteins such as sterol regulatory element binding protein 1c   <cit>  and p <dig>  <cit>  has been shown to be altered by changes in acetylation. the alterations in lysine acetylation in irs- <dig> induced by tsa raised the possibility that insulin signal transduction may be altered in cells after treatment with this compound. to assess the effects of changes in irs- <dig> acetylation on insulin signalling, mcf- <dig> cells were treated with pma, tsa and insulin in different combinations and immunoprecipitated irs- <dig> protein was immunoblotted for the presence of phosphotyrosine. pma alone and in combination with tsa did not increase tyrosine phosphorylation of irs <dig> above basal, as expected . furthermore, the ability of insulin to induce tyrosine phosphorylation of irs- <dig> was reduced by 60% in cells pre-treated with pma  consistent with a state of insulin unresponsiveness. however, pre-treatment with tsa in the presence of pma reduced this unresponsiveness, increasing insulin-stimulated tyrosine phosphorylation to 70% of control . thus, increases in irs <dig> acetylation via tsa-mediated hdac inhibition were able to restore insulin signalling significantly. this restoration occurred without reducing pma-induced serine  <dig> phosphorylation of irs- <dig> , indicating that acetylation of irs <dig> overcomes the inhibitory effects of phosphorylation of serine  <dig> 

to assess the relative roles of altered intracellular protein acetylation and binding of hdac <dig> to irs- <dig> on insulin signalling, we treated cells with the general hat inhibitor, desulfo coenzyme a  and examined hdac2-irs- <dig> interactions and insulin-stimulated tyrosine phosphorylation of irs- <dig>  the data showed that treatment with descoa induced hdac <dig> to bind to irs- <dig> to a similar extent to phorbol ester, which was coincident with reduced insulin-stimulated tyrosine phosphorylation of irs- <dig> . in these experiments, interactions between hdac <dig> and irs- <dig> were apparently weaker in cells treated in the presence of tsa. this is not a consistent phenomenon, and occurs to varying degrees in our experiments . however, tsa has been reported to break other cellular hdac-phosphatase complexes  <cit> , so the effect here on hdac <dig> and irs- <dig> is not unprecedented. treatment of cells with pma and descoa did not lead to significantly greater effects, indicating that the two compounds share a common mechanism of reducing insulin signalling. thus, inhibition of intracellular lysine acetylation accompanied by interactions between irs- <dig> and hdac <dig> leads to compromised insulin signalling, which can be overcome by inhibition of hdac activity. casein kinase ii is an enzyme that has been shown to regulate the ability of hdac <dig> to form oligomeric complexes both positively and negatively  <cit> . interestingly, treatment with an inhibitor of casein kinase ii  did not induce binding between irs- <dig> and hdac <dig>  and had no effect on insulin signalling.

to ascertain if more distal insulin signalling was also enhanced, we examined the activation of protein kinase b  by western blotting, using an antibody against pkb phosphorylated on serine 474; this phosphorylation is induced in a pi3k-sensitive manner resulting in enhanced protein kinase activity. the data showed that pma treatment reduced the activation of pkb by 50% , whereas with pre-treatment with tsa, the response was 80% of control . thus, tsa-mediated increases in lysine acetylation of irs- <dig> led to virtual restoration of pkb activation by insulin in pma-treated cells. interestingly, the pkb response in the presence of tsa and pma  showed significantly higher basal activation of pkb than in unstimulated cells. we speculate that this is due to the recently described ability of hdac inhibitors, including tsa, to activate pkb through an unknown mechanism  <cit> . thus, the increased response of cells to insulin in the presence of tsa  may represent a summation of the effects of tsa alone and insulin. one candidate mechanism for the reported activation of pkb by hdac inhibition is via increased acetylation of irs- <dig> leading to enhanced basal pi3k activity and enhanced pkb activity. we could not, however, detect increases in basal tyrosine phosphorylation of irs- <dig> in the presence of tsa without insulin , suggesting that, if this is indeed part of the mechanism of activation of pkb by hdac inhibition, it is beyond the limits of detection. such a possibility is not without precedent. we have previously reported the ability of a non-specific protein tyrosine phosphatase inhibitor to increase pi3k-dependent glucose transport in muscle cells in culture without being able to detect changes in basal tyrosine phosphorylation of the insulin receptor or irs- <dig>  <cit> . thus, it remains possible that hdac inhibition by tsa leads to enhanced pkb phosphorylation through small changes in irs- <dig> phosphorylation.

a major functional response downstream of the pi3k arm of insulin signal transduction is increased glucose transport mediated by the glut <dig> transporter. we sought to examine the effects of tsa on glucose transport in rat l <dig> myotubes to see if the enhanced insulin signalling mediated by tsa treatment of cells translated into increased glucose uptake. we found that treatment of l <dig> myotubes with pma resulted in increased basal glucose transport and had no effect on insulin-stimulated glucose transport . such effects are in line with data presented for rat epitrochlearis muscle  <cit>  and indicated that l <dig> cells do not exhibit a clear insulin-resistance phenotype after pma treatment, at the level of glucose transport. we also have similar observations in the human neuroblastoma cell line shsy-5y, which demonstrates insulin-stimulated glucose uptake  <cit> . phorbol ester treatment of these cells increased basal glucose transport but in contrast to data in l <dig> cells, also inhibited insulin-stimulated glucose transport . we have therefore not been able to distinguish an effect of tsa on glut4-mediated glucose transport owing to the large pma-stimulated increases in insulin-independent glucose transport , and are at present analysing other cells for their response to phorbol ester treatment. interestingly, takigawa-imamura et al.  <cit>  recently showed that several hdac inhibitors increase glucose transport in muscle cells in culture. although the treatment regimens with these inhibitors in these experiments were chronic, the data show that inhibition of hdac activity enhances glucose transport. molecular mechanisms behind this effect could be several, including enhanced insulin signalling through increases in intracellular protein acetylation.

tsa is an efficacious inhibitor of all class i and class ii hdac enzymes, with a potency in the low nanomolar range. to ascertain whether specific inhibition of hdac <dig> activity is able to enhance insulin signalling in otherwise non-permissive conditions , we used rna interference to reduce hdac <dig> activity specifically. mcf- <dig> cells were transiently transfected with a  <dig> base rna duplex oligonucleotide against hdac <dig> which reduced the hdac <dig> protein content of the cells by approximately 70% . this was associated with a greater than three-fold increase in lysine acetylation of irs- <dig>  furthermore, insulin-stimulated tyrosine phosphorylation of irs- <dig> was increased  <dig> -fold in rnai-treated cells . a second rnai oligonucleotide against hdac <dig> was found to be much less efficient in silencing, exerting no effect on hdac <dig> expression at  <dig> nm . control experiments with this oligonucleotide at concentrations when hdac <dig> expression was unaffected, showed that insulin-stimulated tyrosine phosphorylation of irs- <dig> was not affected , indicating that specific reductions in hdac <dig> after rnai treatment were the main cause of enhanced insulin signalling and irs- <dig> acetylation. these data showed that specific reductions in hdac <dig> activity in mcf- <dig> cells induced similar changes in irs- <dig> regulation as treatment with tsa and that hdac <dig> is an integral component of phorbol ester-induced insulin unresponsiveness in cells. the increase in lysine acetylation and tyrosine phosphorylation was arguably not as marked in rnai-treated cells as in cells treated with tsa. an interpretation of these data could be that other members of the hdac family are also involved in the processes leading to insulin resistance. we have found that hdac <dig> does co-immunoprecipitate with irs- <dig> from mcf- <dig> cells but its regulation is different, with no significant changes in the association by prolonged insulin stimulation or by pma treatment of the cells  suggesting that whatever the involvement of other hdacs, hdac <dig> is central to the observed changes in insulin signalling.

the data we present here imply that treatment of insulin-resistant or diabetic animals with inhibitors of hdac <dig> should increase insulin responsiveness. we attempted to assess the effects of tsa on insulin sensitivity in ob/ob mice. the animals were divided into two groups: vehicle  and tsa  and treated subcutaneously for three days. at the same time as drug injection, all food was withdrawn from the animals and  <dig> hours later, blood was collected from the tail vein for blood glucose and plasma insulin analysis. on the third day, an insulin tolerance test  was performed  <dig> hours after administration of the drug. after  <dig> hours, fasting blood glucose tended to be lower in treated animals than vehicle controls, but after three days no difference was evident. furthermore, we were unable to detect a change in insulin sensitivity after drug treatment during the itt on day  <dig> . in addition, no changes in lysine acetylation of irs- <dig> were observed, indicating that the lack of effect on insulin sensitivity could be due to the inability of tsa to work through the molecular mechanism of increasing irs- <dig> acetylation. tsa is rapidly metabolised by liver cells in culture in two stages, initially by reduction to the imide followed by demethylation, leading to inactive metabolites  <cit> . it is therefore probable that the compound was rapidly metabolised by hepatic phase i metabolic processes in these experiments so that it was unable to exert pharmacodynamic effects on the animals. the poor bioavailability of tsa  <cit>  has led to its discontinuation as a clinical candidate for the treatment of human disease and the possibility of testing the insulin sensitizing effects of hdac inhibition must await the availability of a drug with better pharmacokinetics. furthermore, hdacs are not redundant, but have specific expression patterns and functions. therefore, it is of great importance to develop specific hdac-inhibitors to be able to assess their respective contributions to increases in insulin sensitivity in vivo.

the mechanism whereby lysine acetylation of irs- <dig> leads to increased tyrosine phosphorylation by the insulin receptor is not known. time course experiments, in which cells were stimulated with insulin for one to ten minutes, showed that the kinetics of irs- <dig> phosphorylation were the same, irrespective of pre-treatment of cells with tsa . however, the irs- <dig> tyrosine phosphorylation signal was greater at all times in cells treated with tsa, suggesting that lysine acetylation of irs- <dig> simply increases the amount of phosphorylated irs- <dig>  it has recently been shown that lysine acetylation protects the transcription factor srebp1c from ubiquitination and degradation via the proteasomal pathway by competing for the same lysine residues. irs- <dig> has also been shown to be degraded via ubiquitination and subsequent proteasomal degradation  <cit> . we investigated the influence of lysine acetylation of irs- <dig> on ubiquitination by blotting immunoprecipitates of irs- <dig> from cells for the presence of ubiquitin . the data showed that in the absence of pma, irs- <dig> was only slightly ubiquitinated, whereas in cells treated with pma, this was markedly increased. the molecular mass of both bands of the irs- <dig> doublet increased after pma treatment, spanning  <dig> kd to  <dig> kd, presumably due to the addition of ubiquitin molecules. tsa did not influence pma-induced ubiquitination of irs- <dig>  these data therefore indicate that increases in irs- <dig> phosphorylation after its lysine acetylation are not the result of increasing the concentration of the protein by preventing its degradation. interestingly, a protein called ph domain interacting protein  was recently described that selectively binds in vitro and constitutively associates in cells to the ph-domain of irs- <dig>  <cit> . phip is not itself a substrate of the insulin receptor but rather a ligand of the irs- <dig> ph-domain that serves to link irs- <dig> to the insulin receptor and enhance its phosphorylation. phip contains two bromodomains located in tandem in the centre of the molecule  <cit> . considering the fact that irs- <dig> is acetylated and that bromodomains can interact specifically with acetylated lysine  <cit> , the mode of interaction between phip and irs- <dig> could be through the bromodomains, providing a molecular mechanism that explains why the increased acetylation of irs- <dig>  after tsa treatment, is accompanied by a higher level of tyrosine phosphorylation of irs- <dig> despite the insulin resistant state. we have sought to test this hypothesis by blotting immunoprecipitates of irs- <dig> for phip but have been unable to distinguish a specific band corresponding to phip using the antibodies that are available commercially.

CONCLUSIONS
in this study, we have identified a previously undescribed interaction between irs- <dig> and hdac <dig> in the cytosolic compartment of cells. the interaction is observed both in vitro and in vivo during conditions of compromised insulin signalling, as seen by reductions in insulin-stimulated irs- <dig> tyrosine phosphorylation and pkb activation and increased phosphorylation of the negative regulatory phosphorylation site, serine  <dig>  our data indicate that it is the interaction with hdac <dig> itself rather than its catalytic activity that is integral to the insulin unresponsiveness that ensues. furthermore, our data show that irs- <dig> is a lysine-acetylated protein, a previously unidentified post-translational modification of irs- <dig>  and that increases in the level lysine acetylation of irs- <dig> result in improved insulin signal transduction. increases in irs- <dig> acetylation can be achieved pharmacologically  or by ablation of hdac <dig> specifically by use of rnai. out data therefore indicate that a new dimension to the physiology and pathophysiology of insulin sensitivity and insulin resistance involves changes in the degree of lysine acetylation of irs- <dig> and that specific small molecule inhibitors of hdac <dig> activity could represent novel therapeutics for the treatment of diseases that centre around insulin resistance, such as type  <dig> diabetes and obesity.

